• SENSEX 75,408.69
    949.16 (+1.27%)
  • BANKNIFTY 54,686.95
    -222.70 (--0.41%)
  • Reliance Industries
    1,267.80 1,611.20(%)
  • Jio Platforms
    1,423.30 1,356.40(%)
  • NSE
    1,773.30 1,640.25(%)
  • JSW Steel
    1,310.95 1,350.30(%)
  • Billionbrains
    196.65 227.00(%)
  • Dixon Technolog.
    12,490.00 15,773.95(%)
  • PB Fintech.
    926.00 945.00(%)
  • Aster DM Quality
    673.00 519.80(%)
  • Shriram Finance
    871.25 1,153.65(%)
  • Welspun Living
    243.20 245.70(%)
  • PTC Industries
    24,495.70 26,049.95(%)
  • Rubicon Research
    1,704.65 1,896.15(%)
  • Avenue Super.
    3,218.80 4,642.00(%)
  • Coforge
    2,111.20 2,061.90(%)
  • Netweb Technol.
    3,992.00 2,942.45(%)
  • Cupid
    341.00 369.70(%)
  • Alivus Life
    1,504.00 1,497.00(%)
  • Max Healthcare
    905.35 1,196.50(%)
  • Nippon ETF Liq.
    995.01 978.01(%)
  • Zen Technologies
    1,805.00 2,041.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Novartis India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 243.0
  • ISIN : INE234A01025
1,692.40 -120 (-6.64%)
  • As on 02 Nov 2026 (EOD)

  • Today’s Low

    1,660.00

  • Today’s High

    1,802.00

  • Open

    1,802.00

  • Perv Close

    1,812.80

  • 52W Low

    950.00

  • 52W High

    2,588.80

Key Indicators

  • P/E(TTM)

    42.77

  • Mar.Cap (₹Cr.)

    4,178.67

  • Div & Yield %

    1.48

  • Book Value(₹)

    331.23

  • Debt-Equity Ratio

    -6.64

  • AGM Date

    30-Oct-2026

  • EPS

    39.60

  • P/E Ratio

    42.77

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    4,178.67

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.35

  • BV (₹)

    331.20

  • Sales( ₹ in Cr.)

    376.96

  • NP (in Cr.)

    93.20

  • NP Var(%)

    -8.0

  • Div%

    500.0

  • CPS (₹)

    38.50

  • EPS (₹)

    37.70

  • Traded Value (₹ in Lakhs)

    4,182.25

  • 52 Week High

    2,588.80

  • 52 Week Low

    950.00

  • Price BSE

    1694.0

  • Price NSE

    1,692.00

  • Market Capital( in Cr.)

    4,182.25

  • P/C Ratio

    44.00

  • P/E Ratio

    44.90

  • Price Vs.BV

    37.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 376.96 390.09 366.84 413.52 486.66 453.73
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 376.96 390.09 366.84 413.52 486.66 453.73
Other Income 38.77 41.96 61.68 58.11 33.19 33.09
Stock Adjustments 12.21 -3.75 -9.86 -2.35 9.12 -10.74
Total Income 427.94 428.30 418.66 469.28 528.97 476.08
EXPENDITURE :            
Raw Materials 210.58 199.07 189.98 199.34 187.26 135.88
Power and Fuel Cost 0.11 0.14 0.18 0.35 0.53 0.53
Employee Cost 21.08 18.72 22.96 35.64 101.89 108.51
Other Manufacturing Expenses 9.59 8.18 5.00 12.58 31.15 33.51
Selling and Administration Expenses 47.39 59.74 65.55 82.78 144.40 128.11
Miscellaneous Expenses 6.32 9.07 8.05 15.40 53.08 9.66
Employee Benefit Expenses 21.08 18.72 22.96 35.64 101.89 108.51
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 295.07 294.92 291.72 346.09 518.31 416.20
Operating Profit 132.87 133.38 126.94 123.19 10.66 59.88
Interest 1.26 0.77 1.49 1.75 4.83 7.68
Gross Profit 131.61 132.61 125.45 121.44 5.83 52.20
Depreciation 1.95 2.19 2.61 6.06 9.65 12.16
Profit Before Tax 129.66 130.42 122.84 115.38 -3.82 40.04
Current Tax 34.95 29.96 37.63 1.68 -0.44 22.62
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.53 -0.44 0.02 10.34 0.34 -3.48
Reported Net Profit 93.18 100.90 85.19 103.36 -3.72 20.90
Extraordinary Items -0.02 0.14 1.99 0.17 -44.68 0.03
Adjusted Net Profit 93.20 100.76 83.20 103.19 40.96 20.87
Adjustment below Net Profit 1.42 0.97 1.21 3.11 8.19 -6.09
P & L Balance brought forward 768.98 728.84 759.72 677.94 698.16 708.04
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 61.73 61.73 117.28 24.69 24.69 24.69
P & L Balance carried down 801.85 768.98 728.84 759.72 677.94 698.16
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 500.00 500.00 950.00 200.00 200.00
Dividend Per Share(Rs) 25.00 25.00 25.00 47.50 10.00 10.00
Earnings Per Share-Unit Curr 37.76 40.88 34.52 41.88 -1.51 8.47
Earnings Per Share(Adj)-Unit Curr 37.76 40.88 34.52 41.88 -1.51 8.47
Book Value 331.37 318.06 301.79 314.29 280.27 288.16
Book Value(Adj)-Unit Curr 331.37 318.06 301.79 314.29 280.27 288.16

Shareholding Pattern

  • Promoter Group

    70.68%

  • Public Share Holding

    29.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 13,938,382 56.45 13,938,382 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 13,938,382 56.45 13,938,382 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 965,149 3.91 965,149 1
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 2,547,189 10.32 2,547,189 1
Sub Total 3,512,338 14.23 3,512,338 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,604 0.01 1,907 12
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 300,488 1.22 300,488 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 27,604 0.11 27,604 1
Mutual Funds / UTI 190,717 0.77 190,257 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 150,144 0.61 150,144 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 671,557 2.72 670,400 32
2] Non Institution
Bodies Corporate 588,449 2.38 588,409 232
Clearing Members 9,906 0.04 9,906 27
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 261,071 1.06 259,129 911
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 270,568 1.10 270,558 901
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 637,734 2.58 637,734 6
Individuals holding nominal share capital up to Rs. 1 lakh 4,619,131 18.71 4,425,017 36,000
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 609 0.00 609 2
Others 174,479 0.71 174,479 1
Sub Total 6,568,520 26.60 6,372,289 38,092
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 24,690,797 100.00 24,493,409 38,127

Company Background

Novartis India LtdPharmaceuticals - Multinational

  • Novartis India Ltd
  • BSE Code : 243.0
  • ISIN : INE234A01025

  • Incorporation Year

    1947

  • Registered Office

    The Inspire BKC Part 601 & 701
    Bandra Kurla Complex Bandra(E), Mumbai,
    Maharashtra-400051

  • Telephone

    91-022-50243000

  • FAX

    91-022-50243010

  • Chairman

    C Snook

  • Managing Director

  • Company Secretary

    Chandni Maru

  • Auditor

    B S R & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Novartis India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Novartis India 1,693.85 393.10 354.33 42.77 15.94
Abbott India 25,593.30 7,217.19 6,929.05 33.68 43.78
Astrazeneca Phar 6,367.35 2,304.07 2,275.58 93.84 27.86
Sanofi India 3,204.40 1,857.10 1,837.40 22.79 54.17
Glaxosmi. Pharma 2,483.55 3,932.76 3,790.20 39.67 58.17
Cipla 1,380.00 20,102.60 18,979.95 42.06 13.88
Bliss GVS Pharma 648.40 773.53 729.81 60.26 12.51
Amrutanjan Healt 496.85 520.13 502.55 26.61 24.16
Fermenta Biotec. 417.55 474.15 450.25 19.49 18.77
Guj. Themis Bio. 362.50 168.25 165.82 96.93 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77